BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Plandai Biotechnology, Inc. (PLPL.OB) Announces Intellectual Property Filings


12/11/2013 10:23:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SEATTLE, WA--(Marketwired - December 11, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that over the past several months the company has filed for multiple patents and trademarks as it seeks to protect its intellectual property.

Among the trademarks filed is one covering "Phytofare" for usage in the United States, Canada, and eight other countries. The company also filed a patent titled "System And Method Of Bioavailability Enhancement Of Plant Phytonutrients" and a provisional patent titled "Plant-Based Catechin Compositions." Provisional patents are filed in anticipation of a formal patent application within twelve months and are used to establish the order or precedence in the event a future patent is challenged. Both patents are intended to solidify Plandaí's intellectual property rights with respect to the process by which it creates its plant-based botanical extracts.

As previously discussed, Plandaí uses a proprietary method of extracting phytochemicals from plants. The system, called "hydrodynamic sheering," uses a combination of heat, pressure and hydro-cavitation to unzip living plant molecules and active antioxidants. These released molecules are then reduced into mainly nano-particle size where the antioxidant isomers are realigned making them more compatible with human tissues. The first product which will come to market using this unique process is Phytofare™ Catechin Complex, which is derived from and includes the entire array of catechins found in Green Tea.

Roger Duffield, Chairman and Chief Executive Officer of Plandaí Biotechnology, commented, "As we draw nearer to commencing production and sales of our Phytofare™ products, we want to make sure that our intellectual property is adequately protected. We anticipate filing additional patents covering our other products in the coming months as well as filing for additional trademark protection. For company that is heavily involved in research, this is a critical element of our operations."

The issuance of patents and trademarks can take several months as the various patent offices must determine if there are any competing claims and if the application meets the standards established for granting protection.

About Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its patented Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.

Safe Harbor Statement

The information provided may contain forward-looking statements and involve risks and uncertainties. Results, events and performances could vary from those contemplated. These statements involve risks and uncertainties which may cause actual results, expressed or implied, to differ from predicted outcomes. Risks and uncertainties include product demand, market competition, and Plandaí's ability to meet current or future plans. Investors should study and understand all risks before making an investment decision. Readers are recommended not to place undue reliance on forward-looking statements or information. Plandaí is not obliged to publicly release revisions to any forward-looking statement, to reflect events or circumstances afterward, or to disclose unanticipated occurrences, except as required under applicable laws.


Contact:
Andrew Beyer
Phone: 619-202-7456
Email: investor@Plandaíbiotech.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES